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lation, PUD, GERD, CHF, prevention of complications
of menopause, and flu vaccine administration. 
CONCLUSIONS: These community pharmacists indi-
cated a strong obligation to provide various pharmaceu-
tical care services across all domains measured. The psy-
chosocial domain, which measured the benefit received
by the patient from this service, ranked highest, followed
by the professional domain, indicating that it was the
pharmacist’s professional responsibility to provide this
care. Next in order was the financial domain, which mea-
sured pharmacist reimbursement potential, followed by
the humanistic domain, indicating a nonprofessional (i.e.,
compassionate) reason for providing care.
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OBJECTIVE: The first study objective was to anony-
mously measure the value community pharmacist research
network members placed on the following pharmaceutical
care services: patient counseling, patient education on dis-
ease self-management, and disease screening and detec-
tion. The second objective was to assess the value these
pharmacists placed on providing pharmaceutical care to
patients with 10 specific disease states. 
METHODS: Sixty community pharmacists were mailed
a questionnaire asking them to rank on a scale of 1 to 10
(1  no value; 10  high value) their perceived “value”
of providing pharmaceutical care in the areas of patient
counseling (as defined by OBRA regulations), education
on disease self-management, and disease screening and
detection. They were also asked the perceived “value” of
providing pharmaceutical care in 10 disease areas. In order
to avoid surveyor bias, no specific definition of “value”
was given. 
RESULTS: Thirty-eight pharmacists (63.3%) completed
questionnaires. The average scores were as follows: pa-
tient counseling 7.08  1.82, self management 7.62 
1.46, and disease screening and detection 6.94  1.95.
The average score for all disease areas was 7.36  1.81,
with a range of 5.89 to 8.18. Rank order values for the 10
disease areas were as follows: diabetes 8.18  1.67,
asthma 8.00  1.59, hypertension 7.95  1.89, disorders
requiring anticoagulation 7.50  1.27, hypercholester-
olemia 7.37  1.75, peptic ulcer disease 6.74  1.90,
congestive heart failure 6.68  1.82, gastroesophageal re-
flux disease 6.68  1.88, prevention of menopause com-
plications 6.63  1.88, and flu vaccine administration
5.89  2.40. 
CONCLUSIONS: Pharmacists placed a high value on the
provision of the three evaluated pharmaceutical care ser-
vices. Additionally, pharmacists recognized significant
benefit in the provision of pharmaceutical care for spe-
cific disease states.
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OBJECTIVE: Data from a randomized cohort study are
used to evaluate whether pharmacist consultation (PC)
interventions have a favorable impact on patient survival
and hospitalization. 
METHODS: Since about 80% of the patients switched be-
tween the alternative treatment models of consultation after
initial randomization, the estimated effect of intervention
may be significantly attenuated with a traditional “intent to
treat” analysis. Similarly, time-fixed “as treated” analysis
may also produce biased results because of the use of future
information to predict immediate events. A Cox proportional
hazards model was specified that included multiple time-
dependent intervention variables and other covariates to bet-
ter predict the effect of pharmacy interventions on the event
rate. Specifically, the number of new prescriptions filled over
time at each alternative pharmacist consultation intervention
site was introduced as the intervention variable in order to
measure the extent to which the patient was exposed to each
model of pharmacist consultation at any point in time. Sepa-
rate survival analyses were performed on population sub-
groups defined according to the level of chronic medication
used during the baseline period. Sensitivity analyses were
done under the assumption of informative censoring. 
RESULTS: The KP model pharmacist consultation which
focused increased resources on high-risk patients signifi-
cantly reduced the mortality rate relative to both alternative
pharmaceutical care treatments (State and Control models).
The KP model was also found to decrease the likelihood of
an urgent/emergency hospital admission in a high-risk group
of patients relative to consultation provided only upon pa-
tient request or judgment of the pharmacist. The State
model, which mandated consultation for all new or changed
prescription, was not found to be associated with a risk re-
duction relative to the Control model, but it decreased the
likelihood of death event or a hospital admission relative to
the KP model in the low-risk subgroup. Sensitivity and sub-
set analyses consistently supported these findings. 
CONCLUSION: Focusing more resource intensive consul-
tation on high-risk patients may be a cost-effective way of
providing pharmacist consultation in the outpatient phar-
macy setting.
PPO7
UTILIZATION OF AMBULATORY CARE 
SERVICES DUE TO ADVERSE EFFECTS OF 
MEDICATIONS IN THE UNITED STATES
Aparasu RR, Helgeland DL
College of Pharmacy, South Dakota State University, 
Brookings, SD, USA
